Breakthroughs in US dermal fillers for facial soft-tissue augmentation

Journal of Cosmetic and Laser Therapy

Volumn 11, Issue 4, 2009, Pages 240-247

  Goldberg, David J ^a  

^a Skin Laser and Surgery Specialists of NY/NJ   (United States)

Author keywords

Calcium hydroxylapatite; Collagen; Hyaluronic acid; Injectable devices; Poly L lactic acid

Indexed keywords

ARTECOLL; ARTEFILL; CAPTIQUE; COLLAGEN IMPLANT; CORTICOSTEROID DERIVATIVE; COSMODERM; COSMOPLAST; CYCLOSPORIN; ELEVESS; EVOLENCE; HYALURONIC ACID; HYDROXYAPATITE; JUVEDERM; POLY(METHYL METHACRYLATE); POLYLACTIC ACID; RADIESSE; TACROLIMUS; UNCLASSIFIED DRUG;

DRUG HYPERSENSITIVITY; FACIAL SOFT TISSUE AUGMENTATION; HUMAN; INJECTION SITE CONTUSION; INJECTION SITE EDEMA; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE NODULE; INJECTION SITE SWELLING; PAPULE; PRIORITY JOURNAL; REVIEW; SKIN SCAR; TISSUE REPAIR; WRINKLE;

ANIMALS; CATTLE; COLLAGEN; COSMETIC TECHNIQUES; DURAPATITE; HUMANS; HYALURONIC ACID; LACTIC ACID; POLYMERS; POLYMETHYL METHACRYLATE; SKIN; SKIN AGING; SKIN TESTS; SWINE; UNITED STATES;

EID: 72449133261     PISSN: 14764172     EISSN: 14764180     Source Type: Journal    
DOI: 10.3109/14764170903341731     Document Type: Review

References (57)

1. Zins JE, Moreira-Gonzalez A. Cosmetic procedures for the aging face. Clin Geriatr Med. 2006;22:709-728
2. American Society of Plastic Surgeons. 2000/2005/2006 National Plastic Surgery Statistics. Cosmetic and Reconstructive Procedure Trends. Arlington Heights, Ill: Department of Public Relations.
3. American Society for Aesthetic Plastic Surgery. Cosmetic Plastic Surgery Research Statistics and Trends for 2001-2006. Accessed 2009 March 3. Available from: http://www.cosmeticplasticsurgerystatistics. com/statistics.html
4. Baumann L. Collagen-containing fillers: Alone and in combination. Clin Plast Surg. 2006;33:587-596
5. Bauman L. CosmoDerm/CosmoPlast (human bioengineered collagen) for the aging face. Facial Plast Surg. 2004;20: 125-128
6. Hotta T. Dermal fillers. The next generation. Plast Surg Nurs. 2004;24:14-19.
7. Johl SS, Burgett RA. Dermal filler agents: A practical review. Curr Opin Ophthalmol. 2006;17:471-479
8. ZydermR Collagen Implant Physician Package Insert. Fremont, CA: McGhan Medical Corporation; 2000. Accessed 2009 March 3. URL: http://www.allergan.com/ products/ medical-aesthetics/zyderm-zyplast.htm
9. ZyplastR Collagen Implant physician package insert. Fremont, CA: McGhan Medical Corporation; 2000. Accessed 2009 March 3. URL: http://www.allergan.com/ products/ medical-aesthetics/zyderm-zyplast.htm
10. Eppley BL, Dadvand B. Injectable soft-tissue fillers: Clinical overview. Plast Reconstr Surg. 2006;118:98e-106e.
11. Gordon ML. A conservative approach to the nonsurgical rejuvenation of the face. Dermatol Clin. 2005;23:365-371
12. Baumann L, Kaufman J, Saghari S. Collagen fillers. Dermatol Ther. 2006;19:134-140
13. Rostan E. Collagen fillers. Facial Plast Surg Clin North Am. 2007;15:55-61, vi.
14. Murray CA, Zloty D, Warshawski L. The evolution of soft tissue fillers in clinical practice. Dermatol Clin. 2005;23:343-363
15. Baumann LS, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, et al. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: A multicenter, double-masked, randomized within-subject study. Dermatol Surg. 2007;33:S128-S135.
16. Matarasso SL. The use of injectable collagens for aesthetic rejuvenation. Semin Cutan Med Surg. 2006;25:151-157
17. Cosmoderm™ Prescribing Information. Santa Barbara, CA: Allergan, Inc.; 2007.
18. Cosmoplast™ Package Insert. Santa Barbara, CA: Inamed Corporation; 2003.
19. Smith S, Busso M, McClaren M, Bass LS. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds. Dermatol Surg. 2007;33:S112-21.
20. EvolenceR Collagen Filler 35 mg/ml prescribing information. Herzliya, Israel: ColBar LifeScience Ltd; 2008.
21. Narins RS, Brandt FS, Lorenc ZP, Maas CS, Monheit GD, Smith SR. Twelve-month persistency of a novel ribosecross- linked collagen dermal filler. Dermatol Surg. 2008;34 (suppl 1):S31-9.
22. Lupo MP. Hyaluronic acid fillers in facial rejuvenation. Semin Cutan Med Surg. 2006;25:122-126
23. Monheit GD, Coleman KM. Hyaluronic acid fillers. Dermatol Ther. 2006;19:141-150
24. Clark CP III. Animal-based hyaluronic acid fillers: Scientific and technical considerations. Plast Reconstr Surg. 2007;120: 27S-32S.
25. HylaformR Package Insert. Ridgefi eld, NJ: Genzyme Biosurgery; 2004.
26. RestylaneR Package Insert. Scottsdale, AZ: Medicis Aesthetics, Inc.; 2007.
27. JuvedermR 24HV Prescribing Information. Paris, France: Corneal; 2006.
28. Juvederm™ Ultra Plus Package Insert. Pringy, France: Allergan; 2008.
29. Elevess™ Package Insert. Woburn, MA: Anika Therapeutics, Inc.; 2006.
30. Moers-Carpi M, Vogt S, Martinez Santos B, Planas J, Rovira Vallve S, Howell DJ. A multicenter, randomized trial comparing calcium hydroxylapatite to two hyaluronic acids for treatment of nasolabial folds. Dermatol Surg. 2007;33: S144-51.
31. Lindqvist C, Tveten S, Bondevik BE, Fagrell D. A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds. Plast Reconstr Surg. 2005;115: 282-289
32. Broder KW, Cohen SR. An overview of permanent and semipermanent fillers. Plast Reconstr Surg. 2006;118:7S-14S.
33. Jansen DA, Graivier MH. Evaluation of a calcium hydroxylapatite- based implant (Radiesse) for facial soft-tissue augmentation. Plast Reconstr Surg. 2006;118(3 suppl):22S-30S; discussion 31S-3S.
34. Werschler WP. Combining advanced injection techniques: Poly-L-lactic acid as the foundation for nonsurgical total facial rejuvenation and restoration. Cosmetic Dermatology. 2007;20(suppl 1):9-13.
35. Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. Tissue response and in vivo degradation of selected polyhydroxyacids: Polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3- hydroxyvalerate) (PHB/VA). J Biomed Mater Res. 1993;27:1135-1148
36. Werschler WP, Smith SA. Mechanism of action of polyl- lactic acid: A stimulatory dermal filler. J Drugs Dermatol. 2007;6:s18-s20.
37. SculptraR Prescribing Information. Berwyn, PA: Dermik Laboratories, a business of sanofi -aventis U.S., LLC; 2006.
38. RadiesseR Injectable Implant Package Insert. Franksville, WI: BioForm Medical Inc.; 2006.
39. Kanchwala SK, Holloway L, Bucky LP. Reliable soft tissue augmentation: A clinical comparison of injectable soft-tissue fillers for facial-volume augmentation. Ann Plast Surg. 2005;55:30-35
40. Silvers SL, Eviatar JA, Echavez MI, Pappas AL. Prospective, open-label, 18-month trial of calcium hydroxylapatite (Radiesse) for facial soft-tissue augmentation in patients with human immunodefi ciency virus-associated lipoatrophy: Oneyear durability. Plast Reconstr Surg. 2006;118:34S-45S.
41. Schweiger ES, Riddle CC, Wernli BJ, Viseslav TC. Comparison of poly-l-lactic acid and calcium hydroxylapatite for treating human immunodefi ciency virus-associated facial lipoatrophy. Cosmetic Dermatology. 2007;20:304-312
42. Woerle B, Hanke CW, Sattler G. Poly-L-lactic acid: A temporary filler for soft tissue augmentation. J Drugs Dermatol. 2004;3:385-389
43. Valantin MA, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H, et al. Polylactic acid implants (New- Fill) to correct facial lipoatrophy in HIV-infected patients: Results of the open-label study VEGA. AIDS. 2003;17: 2471-2477
44. Moyle GJ, Brown S, Lysakova L, Barton SE. Long-term safety and efficacy of poly-L-lactic acid in the treatment of HIV-related facial lipoatrophy. HIV Med. 2006;7:181-185
45. Mest DR, Humble G. Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: The US experience. Dermatol Surg. 2006;32:1336-1345
46. Vleggaar D. Facial volumetric correction with injectable poly- L-lactic acid. Dermatol Surg. 2005;31:1511-1517
47. Vleggaar D, Bauer U. Facial enhancement and the European experience with Sculptra (poly-l-lactic acid). J Drugs Dermatol. 2004;3:542-547
48. Lowe NJ. Dispelling the myth: Appropriate use of poly-Llactic acid and clinical considerations. J Eur Acad Dermatol Venereol. 2006;20:2-6.
49. Engelhard P, Humble G, Mest D. Safety of Sculptra: A review of clinical trial data. J Cosmet Laser Ther. 2005;7:201-205
50. Lowe NJ, Maxwell CA, Patnaik R. Adverse reactions to dermal fillers: Review. Dermatol Surg. 2005;31:1616-1625
51. Sadick NS, Burgess C. Clinical experience of adverse outcomes associated with poly-L-lactic acid. J Drugs Dermatol. 2007;6:S4-S8.
52. ArteFillR Prescribing Information. San Diego, CA: Artes Medical, Inc.; 2007.
53. Haneke E. Polymethyl methacrylate microspheres in collagen. Semin Cutan Med Surg. 2004;23:227-232
54. Carruthers JD, Carruthers A. Facial sculpting and tissue augmentation. Dermatol Surg. 2005;31:1604-1612
55. Carruthers A, Carruthers JD. Polymethylmethacrylate microspheres/collagen as a tissue augmenting agent: Personal experience over 5 years. Dermatol Surg. 2005;31: 1561-1564
56. Cohen SR, Holmes RE. Artecoll: A long-lasting injectable wrinkle filler material: Report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg. 2004;114:964-976
57. Bosniak S. Combination therapies: A nonsurgical approach to oculofacial rejuvenation. Ophthalmol Clin North Am. 2005;18:215-25, v.